These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35872581)

  • 1. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
    Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
    J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
    Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
    Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients.
    Cheng S; Yan Z; Ma H; Liu Y
    Ann Hematol; 2024 Sep; 103(9):3649-3656. PubMed ID: 39078433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
    Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
    Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
    Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
    Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
    Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
    Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
    Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
    Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
    Song Y; Yin Q; Wang J; Wang Z
    Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
    Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
    Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lymphocyte function by IFN-γ secretion capability assay in the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Hou H; Luo Y; Wang F; Yu J; Li D; Sun Z
    Hum Immunol; 2019 Dec; 80(12):1006-1011. PubMed ID: 31540793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.
    Chang Y; Cui M; Fu X; Han L; Zhang L; Li L; Li X; Sun Z; Wu J; Zhang X; Li Z; Nan F; Yan J; Sheng G; Zhang M
    Oncol Lett; 2018 Jul; 16(1):1275-1284. PubMed ID: 30061947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
    Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
    Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
    Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.
    Sano H; Kobayashi R; Tanaka J; Hashino S; Ota S; Torimoto Y; Kakinoki Y; Yamamoto S; Kurosawa M; Hatakeyama N; Haseyama Y; Sakai H; Sato K; Fukuhara T
    Br J Haematol; 2014 Jun; 165(6):786-92. PubMed ID: 24606577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
    Yao S; Jin Z; He L; Zhang R; Liu M; Hua Z; Wang Z; Wang Y
    Front Oncol; 2021; 11():788056. PubMed ID: 34938663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
    Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.